InvestorsHub Logo
Followers 13
Posts 2596
Boards Moderated 0
Alias Born 07/05/2016

Re: None

Friday, 05/26/2023 9:34:57 AM

Friday, May 26, 2023 9:34:57 AM

Post# of 1195
I’m afraid the interest has left this company for good. No volume. I’m certain the ceo will go into CE in 2024 and avoid paying the relisting fee for OTC in the States. That fee is nearly $500k a year. It’s an unnecessary expense if he has no volume in trading.